1. Liu, Yu, Du, Feiya, Chen, Wei, Lv, Kezhen, Fu, Peifen. 2014. EIF5A2 is a novel chemoresistance gene in breast cancer. In Breast cancer (Tokyo, Japan), 22, 602-7. doi:10.1007/s12282-014-0526-2. https://pubmed.ncbi.nlm.nih.gov/24638963/
2. Li, Yan, Fu, Li, Li, Jian-Biao, Huang, Peng, Guan, Xin-Yuan. 2014. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. In Gastroenterology, 146, 1701-13.e9. doi:10.1053/j.gastro.2014.02.029. https://pubmed.ncbi.nlm.nih.gov/24561231/
3. Liu, Yuwei, Peng, Li, Chen, Jing, Ye, Xujun, Jin, Yalei. 2023. EIF5A2 specifically regulates the transcription of aging-related genes in human neuroblastoma cells. In BMC geriatrics, 23, 83. doi:10.1186/s12877-023-03793-6. https://pubmed.ncbi.nlm.nih.gov/36750933/
4. Meng, Qing-Bin, Peng, Jing-Jing, Qu, Zi-Wei, Wen, Zhang, Kang, Wei-Ming. . Eukaryotic initiation factor 5A2 and human digestive system neoplasms. In World journal of gastrointestinal oncology, 11, 449-458. doi:10.4251/wjgo.v11.i6.449. https://pubmed.ncbi.nlm.nih.gov/31236196/
5. Wang, Kun, Wang, Yiyang, Wang, Yuanjian, Zhang, Tianli, Yang, Xingsheng. 2021. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis. In Stem cell research & therapy, 12, 186. doi:10.1186/s13287-021-02256-2. https://pubmed.ncbi.nlm.nih.gov/33726845/
6. Fang, Jianwen, Yu, Tianze, Jiang, Xiaocong, Zheng, Jingyan, Fu, Peifen. 2024. Prognostic value of EIF5A2 in solid tumors: A meta-analysis and bioinformatics analysis. In Open medicine (Warsaw, Poland), 19, 20240962. doi:10.1515/med-2024-0962. https://pubmed.ncbi.nlm.nih.gov/38770178/
7. Francis, Jeffrey C, Capper, Amy, Rust, Alistair G, Pettitt, Stephen J, Swain, Amanda. 2024. Identification of genes that promote PI3K pathway activation and prostate tumour formation. In Oncogene, 43, 1824-1835. doi:10.1038/s41388-024-03028-x. https://pubmed.ncbi.nlm.nih.gov/38654106/
8. Wu, Renrui, Zhong, Qiong, Liu, Huafeng, Liu, Shubin. 2023. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway. In Chemical biology & drug design, 102, 815-827. doi:10.1111/cbdd.14293. https://pubmed.ncbi.nlm.nih.gov/37500510/
9. Gao, Jinbo, Li, Peng. 2023. Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells in vitro. In Histology and histopathology, 39, 463-470. doi:10.14670/HH-18-637. https://pubmed.ncbi.nlm.nih.gov/37334930/
智鼠故事 
